Clinical Trial Update: Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hormone therapy to prevent endometrial cancer in women with a genetic risk for Lynch syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED